Update on genomics in veterinary oncology.
The release of an annotated human genome sequence assembly and the emergence of genomics technologies have led to significant advances in our understanding of many human diseases including cancers. As DNA sequencing technology has become less costly, the field of comparative genomics has progressed rapidly and attention has turned now to generating whole genome assemblies and dedicated genomics resources for veterinary species. Such progress brings a whole new series of opportunities to advance veterinary medicine. Many human and animal diseases share a pathogenetic basis, and although veterinary species need advances in biomedical research in their own right, the consideration of companion animals also as good comparative models for human disease saw the emergence of the "one medicine" concept. The future of many areas of human and veterinary biomedical research is very much interdependent, with one of the closest associations being in oncology. It is inevitable that veterinary oncology will benefit enormously from data derived from genomics and that this era will see a huge shift in the ways in which companion animal cancer patients are evaluated and subsequently treated. Here, we will review some of the advancements of genomics as they relate to veterinary oncology.
Breen
Matthew
M
Department of Molecular Biomedical Sciences, College of Veterinary Medicine, and Center for Comparative Medicine and Translational Research, North Carolina State University, Raleigh, NC 27606, USA. Matthew_Breen@ncsu.edu
D000818:Animals; D002371:Cat Diseases / Q000235:genetics*; D002415:Cats; D004283:Dog Diseases / Q000235:genetics*; D004285:Dogs; D023281:Genomics / Q000379:methods*; D009369:Neoplasms / Q000235:genetics* / Q000662:veterinary*; D014730:Veterinary Medicine / Q000379:methods*